Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH)
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0298026 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Joseph Pidala und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States of America. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that causes significant late morbidity and mortality following allogeneic hematopoietic cell transplantation. The “Close Assessment and Testing for Chronic GVHD (CATCH)” study is a multi-center Chronic GVHD Consortium prospective, longitudinal cohort study designed to enroll patients before hematopoietic cell transplantation and follow them closely to capture the development of chronic GVHD and to identify clinical and biologic biomarkers of chronic GVHD onset. Data are collected pre-transplant and every two months through one-year post-transplant with chart review thereafter. Evaluations include clinician assessment of chronic GVHD and its manifestations, patient-reported outcomes, multiple biospecimens (blood, saliva, tears, buccal mucosa and fecal samples, biopsies of skin and mouth), laboratory testing, and medical record abstraction. This report describes the rationale, design, and methods of the CATCH study, and invites collaboration with other investigators to leverage this resource. trial registration : This study is registered at www.clinicaltrials.gov as NCT04188912 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States of America.
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.
- Department of Pediatrics, University of Washington, Seattle, WA, United States of America.
- National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, United States of America.
- Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States of America.
- University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
ORCID-Profile: Marcie Hall
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Pidala, J., Carpenter, P. A., Onstad, L., Pavletic, S. Z., Hamilton, B. K., Chen, G. L., Farhadfar, N., Hall, M., & Lee, S. J. (2024). Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH). PLOS ONE. https://doi.org/10.1371/journal.pone.0298026
Vancouver
Pidala J, Carpenter PA, Onstad L, Pavletic SZ, Hamilton BK, Chen GL, et al. Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH). PLOS ONE. 2024. doi:10.1371/journal.pone.0298026
BibTeX
@article{Pidala2024,
author = {Pidala, Joseph and Carpenter, Paul A and Onstad, Lynn and Pavletic, Steven Z and Hamilton, Betty K and Chen, George L and Farhadfar, Nosha and Hall, Marcie and Lee, Stephanie J},
title = {Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH)},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0298026}
}
EUVIMED